Our guest in this episode is Richard Shah. Richard currently serves as a Project Director and heads up the US Global Engineering Dept at WuXi Biologics.

In this conversation on Design, Build and Deliver with Hart Companies with host Samir Gondalia, Richard shares his journey from being a chemist to leading global life science projects. He discusses the nuances of managing projects across different regions, the importance of site selection, and the evolving conversation around speed to market in the pharmaceutical industry. Richard also highlights the design drivers for biopharma facilities and the future technologies that will shape the industry, including the role of AI and digitalization. The discussion concludes with personal insights and reflections on the industry.

Takeaways
- Richard's transitioned from a chemist to a global engineering leader.
- Site selection involves multiple factors including tax incentives and labor market.
- Speed to market has become a critical focus post-COVID.
- Design drivers for biopharma include ESG, single-use technology, and digitalization.
- Flexibility and future-proofing are essential in facility design.
- Cost differentials exist between construction in the US and Ireland.
- Single-use technologies are preferred for speed and flexibility.
- Richard emphasizes the importance of continuous learning and adaptation.

Quotable quotes:
"Flexibility and future proofing are key."
"Good data is confidential."

Whether you are a global life science facilities leader or an industry follower, this episode is full of real-world insights and implementable tips.

The links to the various platforms are in comments.

My guest in this episode is George Skillin. George is VP of Strategy Services with Project Farma, a Perkin Elmer Company. George has over 35 years of BioPharmaceutical Experience in all aspects of manufacturing including Bulk Active Ingredient, Biotech Drug Substance, Aseptic Processing & Filling, Packaging and Serialization.

In this conversation, George and I discuss the intricacies of designing, building, and delivering life science facility projects. We explore the importance of speed and quality in project delivery, effective budget management, and the critical role of operational readiness. Our discussion also highlights changes in the industry post-COVID, the significance of local sourcing for talent, and the challenges of scaling up processes. Additionally, we touch on the potential impact of AI in validation and commissioning, future trends in facility design, and the need for robust training programs to address the talent shortage in the life sciences sector.

Key Takeaways:

• Good planning and scheduling are crucial for speed.
• Managing scope tightly minimizes project changes.
• Operational readiness should start during facility construction.
• Life science facilities are increasingly modular and prefabricated.
• Local sourcing of talent is becoming a priority.
• AI has potential but lacks real-world applications in validation.
• Training programs are essential for new hires in GMP environments.
• The industry faces a talent shortage as investments increase.
• Process development must align with facility capabilities.
• Future trends include a focus on smaller, more efficient facilities.

Quotable quotes:

• "Good planning and scheduling are crucial for speed."
• "Managing scope tightly minimizes project changes."
• "Local sourcing of talent is becoming a priority."

I have known George for many years and worked with him during our Pfizer days.
I thoroughly enjoyed talking to him in this chat. Hope you do too.

Here's George Skillin.

My guest in this episode is James O'Keefe. James is Vice President at Hart Engineering Corporation, where he oversees complex mechanical construction projects across the life sciences, pharmaceutical, and industrial sectors. Since joining Hart in 2008 as a Northeastern University Co-Op student, James has advanced through multiple engineering and project management roles. From a Co-op to VP - a real example if you need one.

With nearly 20 years of experience, he has led some of Hart's most demanding installations in New England. He is deeply engaged in advancing life science industry standards through active participation in the New England Mechanical Contractors Association (NEMCA), the International Society for Pharmaceutical Engineers (ISPE), and the UA Local 51 Joint Apprenticeship Training Committee (JATC). Jim holds a degree in Mechanical Engineering from Northeastern University.

In this chat, Jim and I delve into
- the intricacies of capital projects,
- the differences between design build and design assist methodologies,
- the importance of various drawing types in project management,
- strategies to avoid delays and cost overruns, and
- the growing trend of local sourcing in the life science construction industry.

Additionally, we address the critical shortage of skilled labor and the value of apprenticeship programs, while also touching on personal insights regarding work-life balance and the importance of effective communication in project execution.

Takeaways:

• Design build integrates engineering and contracting under one entity.
• Design assist involves contractor input during the design phase.
• Different drawing types serve specific purposes in project management.
• Early conversations with stakeholders can prevent project delays.
• Local sourcing is becoming more popular for better control and quality.
• Choosing the right materials can lead to significant cost savings.
• The construction industry faces a shortage of skilled labor.
• Apprenticeship programs provide valuable education without debt.
• Work-life balance is essential for long-term career satisfaction.

Quatable Quotes:

• "It's a lot easier to change things on paper than in a facility."
• "We can streamline everything."

Jim can be reached at jokeefe(at)hartcompanies.com and on LinkedIn.

I found my discussion with Jim very timely and insightful. I hope you do too.

Here's James O'Keefe.